Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 305

1.

Combining PARP inhibition, radiation, and immunotherapy: A possible strategy to improve the treatment of cancer?

Césaire M, Thariat J, Candéias SM, Stefan D, Saintigny Y, Chevalier F.

Int J Mol Sci. 2018 Nov 28;19(12). pii: E3793. doi: 10.3390/ijms19123793. Review.

2.

Intra- and subretinal neovascularization following radiation therapy: Contribution of OCT-angiography.

Mathis T, Levron A, Pommier P, Denis P, Thariat J, Kodjikian L.

J Fr Ophtalmol. 2018 Nov 13. pii: S0181-5512(18)30410-8. doi: 10.1016/j.jfo.2018.04.007. [Epub ahead of print] No abstract available.

PMID:
30446345
3.

Regression rate of choroidal melanoma following iodine-125 brachytherapy is not associated with metastatic spread.

Pépin F, Julien AS, Fugaru I, Lihimdi N, Thariat J, Landreville S, Mouriaux F.

Melanoma Res. 2018 Oct 31. doi: 10.1097/CMR.0000000000000540. [Epub ahead of print]

PMID:
30383721
4.

20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas.

Bellocq D, Roy P, Kodjikian L, Mathis T, Nguyen AM, Herault J, Rivoire M, Négrier S, Thariat J, Grange JD.

Melanoma Res. 2018 Oct 12. doi: 10.1097/CMR.0000000000000519. [Epub ahead of print]

PMID:
30320630
5.

Safety of combined PD-1 pathway inhibition and radiation therapy for non-small-cell lung cancer: A multicentric retrospective study from the GFPC.

Lesueur P, Escande A, Thariat J, Vauléon E, Monnet I, Cortot A, Lerouge D, Danhier S, Dô P, Dubos-Arvis C, Chouaïd C, Gervais R.

Cancer Med. 2018 Nov;7(11):5505-5513. doi: 10.1002/cam4.1825. Epub 2018 Oct 11.

6.

New concepts in the diagnosis and management of choroidal metastases.

Mathis T, Jardel P, Loria O, Delaunay B, Nguyen AM, Lanza F, Mosci C, Caujolle JP, Kodjikian L, Thariat J.

Prog Retin Eye Res. 2018 Sep 19. pii: S1350-9462(18)30029-6. doi: 10.1016/j.preteyeres.2018.09.003. [Epub ahead of print] Review.

7.

[Management of uveal melanomas, guidelines for oncologists].

Mathis T, Cassoux N, Tardy M, Piperno S, Gastaud L, Dendale R, Maschi C, Nguyen AM, Meyer L, Bonnin N, Baillif S, Tick S, Mouriaux F, Jaspart F, Dellis J, Rosier L, Desjardins L, Herault J, Caujolle JP, Thariat J.

Bull Cancer. 2018 Oct;105(10):967-980. doi: 10.1016/j.bulcan.2018.07.011. Epub 2018 Sep 11. Review. French.

PMID:
30217336
8.

Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy.

Boughzala-Bennadji R, Stoeckle E, Le Péchoux C, Méeus P, Honoré C, Attal J, Duffaud F, De Pinieux G, Bompas E, Thariat J, Leroux A, Bertucci F, Isambert N, Delcambre C, Blay JY, Sunyach MP, Coindre JM, Sargos P, Penel N, Bonvalot S.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):399-406. doi: 10.1016/j.ijrobp.2018.05.055. Epub 2018 Jun 2.

PMID:
30191871
9.

Practical contouring guidelines with an MR-based atlas of brainstem structures involved in radiation-induced nausea and vomiting.

Beddok A, Faivre JC, Coutte A, Guévelou JL, Welmant J, Clavier JB, Guihard S, Janoray G, Calugaru V, Pointreau Y, Lacout A, Salleron J, Lefranc M, Hasboun D, Duvernoy HM, Thariat J.

Radiother Oncol. 2018 Aug 29. pii: S0167-8140(18)33441-8. doi: 10.1016/j.radonc.2018.08.003. [Epub ahead of print]

PMID:
30172454
10.

[Surgery or radiotherapy for oropharyngeal HPV-positive tumours?]

Philouze P, Céruse P, Thariat J.

Cancer Radiother. 2018 Oct;22(6-7):481-486. doi: 10.1016/j.canrad.2018.07.125. Epub 2018 Aug 23. Review. French.

PMID:
30145091
11.

Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy.

Klausner G, Blais E, Jumeau R, Biau J, de Meric de Bellefon M, Ozsahin M, Zilli T, Miralbell R, Thariat J, Troussier I.

Med Oncol. 2018 Aug 20;35(10):134. doi: 10.1007/s12032-018-1197-1. Review.

PMID:
30128811
12.

[Proton therapy in soft tissue and bone sarcomas].

Thariat J, Tessonnier T, Bonvalot S, Lerouge D, Mammar H, Bolle S, Claren A, Duffaud F, Alapetite C, Vogin G.

Bull Cancer. 2018 Sep;105(9):830-838. doi: 10.1016/j.bulcan.2018.05.008. Epub 2018 Aug 17. Review. French.

PMID:
30126610
13.

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).

Lesueur P, Lequesne J, Barraux V, Kao W, Geffrelot J, Grellard JM, Habrand JL, Emery E, Marie B, Thariat J, Stefan D.

Radiat Oncol. 2018 Jul 28;13(1):138. doi: 10.1186/s13014-018-1083-1.

14.

[Genomic characterization of head and neck squamous cell carcinoma: Impact and challenges for therapeutic management].

Saada-Bouzid E, Milano G, Thariat J.

Bull Cancer. 2018 Sep;105(9):820-829. doi: 10.1016/j.bulcan.2018.05.011. Epub 2018 Jun 22. Review. French.

PMID:
29937334
15.

Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN.

Weber DC, Habrand JL, Hoppe BS, Hill Kayser C, Laack NN, Langendijk JA, MacDonald SM, McGovern SL, Pater L, Perentesis JP, Thariat J, Timmerman B, Yock TI, Mahajan A.

Radiother Oncol. 2018 Jul;128(1):44-55. doi: 10.1016/j.radonc.2018.05.020. Epub 2018 Jun 21. Review.

PMID:
29937209
16.

[Definitions of oligometastatic disease and new treatment concepts].

Kissel M, Helou J, Thariat J.

Bull Cancer. 2018 Jul - Aug;105(7-8):696-706. doi: 10.1016/j.bulcan.2018.04.012. Epub 2018 Jun 20. Review. French.

PMID:
29935914
17.

[Proton therapy in advanced lung cancer, a clinical phase III trial].

Kao W, Thariat J.

Bull Cancer. 2018 Jul - Aug;105(7-8):634-635. doi: 10.1016/j.bulcan.2018.04.010. Epub 2018 Jun 7. French. No abstract available.

PMID:
29887286
18.

Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.

Chaikh A, Calugaru V, Bondiau PY, Thariat J, Balosso J.

Int J Radiat Biol. 2018 Sep;94(9):789-797. doi: 10.1080/09553002.2018.1486516. Epub 2018 Jul 16.

PMID:
29878849
19.

[Focus on clinical and pathological management of conjunctival melanocytic tumors].

Lassalle S, Caujolle JP, Leger F, Maschi C, Gastaud L, Nahon-Esteve S, Thariat J, Baillif S, Hofman P.

Ann Pathol. 2018 Jun;38(3):153-163. doi: 10.1016/j.annpat.2018.03.006. Epub 2018 May 24. French.

PMID:
29803361
20.

Occurrence of Phosphenes in Patients Undergoing Proton Beam Therapy for Ocular Tumor.

Mathis T, Hofverberg P, Caujolle JP, Hérault J, Leal C, Maschi C, Delaunay B, Baillif S, Kodjikian L, Thariat J.

Am J Ophthalmol. 2018 Aug;192:31-38. doi: 10.1016/j.ajo.2018.05.006. Epub 2018 May 26.

PMID:
29753854

Supplemental Content

Loading ...
Support Center